Watchful waiting vs surgery: new study on tiny thyroid tumors
NCT ID NCT04624477
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two ways to manage very small, low-risk papillary thyroid cancers: active surveillance (regular check-ups to monitor the cancer) or immediate surgery. Researchers are tracking 450 adults over time to see how often each approach meets long-term goals, such as avoiding cancer growth or the need for extra treatments. The goal is to help patients and doctors make better-informed choices.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 450 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2021
- Expected to finish
-
Dec 2034
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults (aged 18 years of age or older) with small (\< 2cm maximal diameter) low risk papillary thyroid cancer that is confined to the thyroid (with no evidence of metastatic disease, no extrathyroidal extension, which is not in a location that is of high risk for invasion of the trachea or recurrent laryngeal nerve).
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients 18 years of age or older. * Newly diagnosed previously surgically untreated papillary thyroid cancer (PTC) or suspicious for PTC on fine needle aspiration biopsy of the thyroid. PTC must be \< 2 cm in maximal diameter on thyroid ultrasound. * The absence of metastatic cervical lymphadenopathy or gross extrathyroidal extension of PTC, as confirmed on neck ultrasound imaging. * The absence of other current absolute indication for thyroid or parathyroid surgery (e.g. severe hyperthyroidism that cannot be controlled medically, large goitre with severe compressive symptoms, or primary hyperthyroidism meeting surgical criteria). Exclusion Criteria: * Metastatic thyroid cancer (lymph nodes or distant). * History of prior thyroid surgery for any indication. * The primary PTC being on the trachea or immediately adjacent to the recurrent laryngeal nerve, and with progression would be deemed to be at high risk of growth into these critical structures. * Clinical signs, imaging, or laryngoscopy findings suggestive of locally advanced thyroid cancer (i.e. vocal cord paralysis due to the thyroid cancer or any clinical or radiographic signs of extrathyroidal invasion into adjacent structures such as the strap muscles of the neck, trachea or esophagus). * Known/suspected poorly differentiated or non-papillary thyroid cancer. * Medically unfit for surgery due to severe co-morbidity. Severe comorbidity may include another active malignancy with limited life expectancy of \< 1 year). * Pregnancy at the time of study enrollment. * Unable/unwilling to provide informed consent for the study or comply with study follow-up procedures due to current active physical limitations/medical co-morbidity, cognitive, or psychiatric impairment substance abuse, or other reasons.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Papillary microcarcinoma of the thyroid are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Québec - Université Laval
Québec, Quebec, G1V 4G2, Canada
-
Division chirurgie ORL et cervico-faciale
Montreal, Quebec, Canada
-
Lawson Health Research Institute
London, Ontario, N6C2R5, Canada
-
Nova Scotia Health
Halifax, Nova Scotia, B3H1V8, Canada
-
St. Joseph's Healthcare
Hamilton, Ontario, Canada
-
University Health Network
Toronto, Ontario, M5G 2C4, Canada
-
University of British Columbia
Vancouver, British Columbia, V5Z 1M9, Canada
-
University of Calgary, Cumming School of Medicine
Calgary, Alberta, T2N 2T9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Freezing out thyroid tumors: a new weapon in the fight?
- Scientists mine 1,100 patient records to spot thyroid cancer return risks
- Robotic surgery through the mouth could eliminate neck scars in thyroid cancer patients
- AI assistant aims to ease thyroid cancer anxiety before surgery
- Real-Time tissue test may help surgeons avoid unnecessary neck dissections in thyroid cancer
- Hidden thyroid cancers: how common are they in patients with thyroiditis?